Search research articles
Contact Us
Filters
Showing results (11-20 of 292) with videos related to
Page
of 30
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2011
Personalized tamoxifen: what is the best way forward?
James M Rae
Clinical Pharmacology and Therapeutics
|
July 23, 2013
CYP2D6 genotype should not be used to determine endocrine therapy in postmenopausal breast cancer patients
J M Rae
Science (New York, N.Y.)
|
December 3, 1976
Hydroxymethyluracil in eukaryote DNA: a natural feature of the pyrrophyta (dinoflagellates)
P M Rae
The Journal of Cell Biology
|
July 1, 1970
The nature and processing of ribosomal ribonucleic acid in a dinoflagellate
P M Rae
Nucleic Acids Research
|
October 10, 1981
Coding region deletions associated with the major form of rDNA interruption in Drosophila
P M Rae
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1973
5-Hydroxymethyluracil in the DNA of a dinoflagellate
P M Rae
Journal of Public Health Medicine
|
March 1, 1997
Training public health practitioners in the National Health Service
M Rae, P Milner
Expert Reviews in Molecular Medicine
|
November 21, 2008
Pharmacogenetics and breast cancer endocrine therapy: CYP2D6 as a predictive factor for tamoxifen metabolism and drug response?
Vered Stearns, James M Rae
The Medical Journal of Australia
|
July 1, 2016
Carers of Indigenous children: services and systems failure? Where to next?
Beth Mah, Kym M Rae
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|
April 25, 2002
Using a grid framework to aid constructive thinking
L Cook, K M Rae
Page
of 30
Search research articles
Search
Showing results (11-20 of 292) with videos related to
Sort By:
Page
of 30
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2011
Personalized tamoxifen: what is the best way forward?
James M Rae
Clinical Pharmacology and Therapeutics
|
July 23, 2013
CYP2D6 genotype should not be used to determine endocrine therapy in postmenopausal breast cancer patients
J M Rae
Science (New York, N.Y.)
|
December 3, 1976
Hydroxymethyluracil in eukaryote DNA: a natural feature of the pyrrophyta (dinoflagellates)
P M Rae
The Journal of Cell Biology
|
July 1, 1970
The nature and processing of ribosomal ribonucleic acid in a dinoflagellate
P M Rae
Nucleic Acids Research
|
October 10, 1981
Coding region deletions associated with the major form of rDNA interruption in Drosophila
P M Rae
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1973
5-Hydroxymethyluracil in the DNA of a dinoflagellate
P M Rae
Journal of Public Health Medicine
|
March 1, 1997
Training public health practitioners in the National Health Service
M Rae, P Milner
Expert Reviews in Molecular Medicine
|
November 21, 2008
Pharmacogenetics and breast cancer endocrine therapy: CYP2D6 as a predictive factor for tamoxifen metabolism and drug response?
Vered Stearns, James M Rae
The Medical Journal of Australia
|
July 1, 2016
Carers of Indigenous children: services and systems failure? Where to next?
Beth Mah, Kym M Rae
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|
April 25, 2002
Using a grid framework to aid constructive thinking
L Cook, K M Rae
Page
of 30